Philip S Wang

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint Improving mental health treatments through comparative effectiveness research
    Philip S Wang
    National Institute of Mental Health NIMH in Bethesda, Maryland, USA
    Health Aff (Millwood) 28:783-91. 2009
  2. pmc Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys
    Philip S Wang
    Division of Services and Intervention Research, National Institute of Mental Health, Rockville, MD, USA
    Lancet 370:841-50. 2007
  3. pmc The impact of cost sharing on antidepressant use among older adults in British Columbia
    Philip S Wang
    National Institute of Mental Health, Bethesda, MD 20892 9629, USA
    Psychiatr Serv 59:377-83. 2008
  4. ncbi request reprint The costs and benefits of enhanced depression care to employers
    Philip S Wang
    Department of Psychiatry, Brigham and Women s Hospital, 75 Francis Street, Boston, MA, USA
    Arch Gen Psychiatry 63:1345-53. 2006
  5. doi request reprint Making the business case for enhanced depression care: the National Institute of Mental Health-harvard Work Outcomes Research and Cost-effectiveness Study
    Philip S Wang
    Division of Services and Intervention Research, National Institute of Mental Health, Rockville, MD 20892 9629, USA
    J Occup Environ Med 50:468-75. 2008
  6. doi request reprint Bridging bench and practice: translational research for schizophrenia and other psychotic disorders
    Philip S Wang
    Division of Services and Intervention Research, National Institute of Mental Health, Rockville, MD 20852, USA
    Neuropsychopharmacology 34:204-12. 2009
  7. pmc Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial
    Philip S Wang
    Division of Services and Intervention Research, National Institute of Mental Health, Rockville, Maryland, USA
    JAMA 298:1401-11. 2007
  8. pmc Invited Commentary: Assessing treatment effects by using observational analyses--opportunities and limitations
    Philip S Wang
    National Institute of Mental Health, NIH, Bethesda, MD 20892 9669, USA
    Am J Epidemiol 170:286-7; discussion 288. 2009
  9. pmc Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    Arch Gen Psychiatry 67:497-506. 2010
  10. ncbi request reprint Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Kidney Dis 46:1080-7. 2005

Detail Information

Publications81

  1. doi request reprint Improving mental health treatments through comparative effectiveness research
    Philip S Wang
    National Institute of Mental Health NIMH in Bethesda, Maryland, USA
    Health Aff (Millwood) 28:783-91. 2009
    ..We use several recent comparative effectiveness trials to illustrate the potential value of such research for improving practice and policy...
  2. pmc Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys
    Philip S Wang
    Division of Services and Intervention Research, National Institute of Mental Health, Rockville, MD, USA
    Lancet 370:841-50. 2007
    ..We describe mental health care in 17 countries participating in the WHO world mental health (WMH) survey initiative and examine unmet needs for treatment...
  3. pmc The impact of cost sharing on antidepressant use among older adults in British Columbia
    Philip S Wang
    National Institute of Mental Health, Bethesda, MD 20892 9629, USA
    Psychiatr Serv 59:377-83. 2008
    ....
  4. ncbi request reprint The costs and benefits of enhanced depression care to employers
    Philip S Wang
    Department of Psychiatry, Brigham and Women s Hospital, 75 Francis Street, Boston, MA, USA
    Arch Gen Psychiatry 63:1345-53. 2006
    ..Although outreach and enhanced treatment interventions improve depression outcomes, uptake has been poor in part because purchasers lack information on their return on investment...
  5. doi request reprint Making the business case for enhanced depression care: the National Institute of Mental Health-harvard Work Outcomes Research and Cost-effectiveness Study
    Philip S Wang
    Division of Services and Intervention Research, National Institute of Mental Health, Rockville, MD 20892 9629, USA
    J Occup Environ Med 50:468-75. 2008
    ..Explore the business case for enhanced depression care and establish a return on investment rationale for increased organizational involvement by employer-purchasers...
  6. doi request reprint Bridging bench and practice: translational research for schizophrenia and other psychotic disorders
    Philip S Wang
    Division of Services and Intervention Research, National Institute of Mental Health, Rockville, MD 20852, USA
    Neuropsychopharmacology 34:204-12. 2009
    ..Recent examples of T1 and T2 research in schizophrenia and other psychotic disorders as well as strategies for better linking T1 and T2 research agendas are covered...
  7. pmc Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial
    Philip S Wang
    Division of Services and Intervention Research, National Institute of Mental Health, Rockville, Maryland, USA
    JAMA 298:1401-11. 2007
    ..Organized depression care programs significantly improve treatment quality, but employer purchasers have been slow to adopt these programs based on lack of evidence for cost-effectiveness from their perspective...
  8. pmc Invited Commentary: Assessing treatment effects by using observational analyses--opportunities and limitations
    Philip S Wang
    National Institute of Mental Health, NIH, Bethesda, MD 20892 9669, USA
    Am J Epidemiol 170:286-7; discussion 288. 2009
    ..However, the authors' study is unlikely to address other potential sources of bias, which may make interpretation of their findings more difficult...
  9. pmc Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    Arch Gen Psychiatry 67:497-506. 2010
    ..This prompted a meta-analysis of trials in adults that found no overall increase in risk, but individual agents could not be studied...
  10. ncbi request reprint Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Kidney Dis 46:1080-7. 2005
    ..However, little is known about the adequacy of adherence to these guidelines in elderly patients with diabetes and predictors of such appropriate ACE-inhibitor or ARB use...
  11. doi request reprint Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications
    Soko Setoguchi
    Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    J Am Geriatr Soc 56:1644-50. 2008
    ....
  12. pmc Changing profiles of service sectors used for mental health care in the United States
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 163:1187-98. 2006
    ..Redesigning the fragmented U.S. mental health care system requires knowing how service sectors share responsibility for individuals' mental health needs...
  13. pmc Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 163:1561-8. 2006
    ..Bipolar disorder has been overlooked both because of the failure to distinguish between major depressive disorder and bipolar disorder and by the failure to evaluate the workplace costs of mania/hypomania...
  14. pmc Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Gigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    J Gen Intern Med 19:444-50. 2004
    ..We sought to evaluate and rank the performance of comorbidity scores across selected U.S. and Canadian elderly populations using health care utilization databases...
  15. ncbi request reprint Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects?
    M Alan Brookhart
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital Harvard Medical School, Boston, Massachusetts, USA
    Med Care 45:S116-22. 2007
    ..We sought to explore the validity of physician-level IV in a comparative study of short-term mortality risk among elderly users of conventional versus atypical antipsychotic medications (APM)...
  16. ncbi request reprint Risk of death in elderly users of conventional vs. atypical antipsychotic medications
    Philip S Wang
    Department of Psychiatry, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    N Engl J Med 353:2335-41. 2005
    ..However, the advisory did not apply to conventional antipsychotic medications; the risk of death with these older agents is not known...
  17. pmc Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants
    Philip S Wang
    National Institute of Mental Health, 6001 Executive Blvd, Room 8229, MSC 9669, Bethesda, MD 20892, USA
    J Ment Health Policy Econ 13:37-44. 2010
    ..The transition between the two policies is analogous to what many U.S. seniors experience when they transition from private insurance requiring copays to Medicare Part D requiring deductibles and coinsurance...
  18. pmc Disruption of existing mental health treatments and failure to initiate new treatment after Hurricane Katrina
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 165:34-41. 2008
    ..The authors examined the disruption of ongoing treatments among individuals with preexisting mental disorders and the failure to initiate treatment among individuals with new-onset mental disorders in the aftermath of Hurricane Katrina...
  19. pmc Individual and societal effects of mental disorders on earnings in the United States: results from the national comorbidity survey replication
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 165:703-11. 2008
    ..The purpose of this report was to update previous estimates of the association between mental disorders and earnings. Current estimates for 2002 are based on data from the National Comorbidity Survey Replication (NCS-R)...
  20. ncbi request reprint Assessing health state utilities in elderly patients at cardiovascular risk
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Med Decis Making 26:247-54. 2006
    ..Health state preferences can be a crucial component of cost-effectiveness analyses, but off-the-shelf health state utilities specifically for older people are not available...
  21. ncbi request reprint Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Arch Gen Psychiatry 62:629-40. 2005
    ..Dramatic changes have occurred in mental health treatments during the past decade. Data on recent treatment patterns are needed to estimate the unmet need for services...
  22. pmc When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study
    Roy H Perlis
    Center for Human Genetics Research, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Neuropsychopharmacology 34:2227-36. 2009
    ..These circumstances, particularly availability of alternative treatment strategies and test effect sizes, can be estimated and should be considered before these tests are broadly applied in clinical settings...
  23. pmc Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts
    Sebastian Schneeweiss
    Harvard Medical School, Brigham and Women s Hospital, Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Boston, MA 02120, USA
    Pediatrics 125:876-88. 2010
    ..The objective of this study was to assess the risk of suicide attempts and suicides after initiation of antidepressant medication use by children and adolescents, for individual agents...
  24. ncbi request reprint Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Hypertension 46:273-9. 2005
    ..Highly prevalent, noncardiovascular conditions appear to deter use of antihypertensives in elderly with hypertension...
  25. ncbi request reprint Effects of major depression on moment-in-time work performance
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 161:1885-91. 2004
    ..The authors used the experience sampling method to address this problem by collecting comparative data on moment-in-time work performance among service workers who were depressed and those who were not depressed...
  26. ncbi request reprint Racial differences in screening for prostate cancer in the elderly
    Timothy Gilligan
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Arch Intern Med 164:1858-64. 2004
    ..Low screening rates among black men may contribute to these disparities, but there are few data on racial differences in prostate cancer screening...
  27. ncbi request reprint Self-management education programs in chronic disease: a systematic review and methodological critique of the literature
    Asra Warsi
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02120, USA
    Arch Intern Med 164:1641-9. 2004
    ..We evaluated the efficacy of patient self-management educational programs for chronic diseases and critically reviewed their methodology...
  28. ncbi request reprint Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Arch Gen Psychiatry 62:603-13. 2005
    ..An understudied crucial step in the help-seeking process is making prompt initial contact with a treatment provider after first onset of a mental disorder...
  29. ncbi request reprint Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic model
    Roy H Perlis
    Pharmacogenomics Research Program, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    J Clin Psychopharmacol 25:427-34. 2005
    ..More consistent reporting of test parameters such as sensitivity and specificity would greatly facilitate assessment of future pharmacogenetic studies...
  30. ncbi request reprint Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Annu Rev Clin Psychol 3:137-58. 2007
    ..The article closes with a discussion of future directions for research...
  31. ncbi request reprint Suboptimal antidepressant use in the elderly
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    J Clin Psychopharmacol 25:118-26. 2005
    ..Suboptimal antidepressant use remains common in the elderly, especially the use of inadequately intensive regimens. Interventions are needed to improve the quality and outcomes of antidepressant use in this vulnerable population...
  32. ncbi request reprint Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030 Boston, MA 02120, USA
    J Ment Health Policy Econ 7:77-85. 2004
    ..Clozapine is currently restricted to patients who have failed at least two trials of other antipsychotic medications because of concerns that its use as a first-line agent would lead to greater mortality, mainly through agranulocytosis...
  33. ncbi request reprint Use of the case-crossover design to study prolonged drug exposures and insidious outcomes
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Ann Epidemiol 14:296-303. 2004
    ..We investigated whether case-crossover methods can be used to study prolonged exposures and insidious outcomes...
  34. pmc The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
    Epidemiol Psichiatr Soc 18:23-33. 2009
    ..The paper reviews recent findings from the WHO World Mental Health (WMH) surveys on the global burden of mental disorders...
  35. ncbi request reprint Instrumental variable analysis of secondary pharmacoepidemiologic data
    M Alan Brookhart
    Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women s Hospital, Boston, MA 02120, USA
    Epidemiology 17:373-4. 2006
  36. pmc Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School, Brigham and Women s Hospital, Boston, Massachusetts, USA
    CNS Drugs 23:171-80. 2009
    ..Nonrandomised studies on the causal effects of psychotropic medications may be biased by patient characteristics that are not fully adjusted...
  37. ncbi request reprint Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis
    Sebastian Schneeweiss
    Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics, Boston, MA 021205, USA
    Arthritis Rheum 54:3390-8. 2006
    ....
  38. pmc Improved comorbidity adjustment for predicting mortality in Medicare populations
    Sebastian Schneeweiss
    Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Health Serv Res 38:1103-20. 2003
    ..To define and improve the performance of existing comorbidity scores in predicting mortality in Medicare enrollees...
  39. ncbi request reprint Prescription opioid use among older adults with arthritis or low back pain
    Daniel H Solomon
    Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Ste, 3030, Boston, MA 02120, USA
    Arthritis Rheum 55:35-41. 2006
    ..To examine patterns of chronic opioid use in selected groups with arthritis and low back pain and compare them with patterns among persons with ischemic heart disease...
  40. doi request reprint The descriptive epidemiology of commonly occurring mental disorders in the United States
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Annu Rev Public Health 29:115-29. 2008
    ....
  41. pmc The prevalence and correlates of workplace depression in the national comorbidity survey replication
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    J Occup Environ Med 50:381-90. 2008
    ..To review evidence on the workplace prevalence and correlates of major depressive episodes, with a particular focus on the National Comorbidity Survey Replication, the most recent national survey to focus on these issues...
  42. pmc Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 021205, USA
    CMAJ 176:627-32. 2007
    ..We assessed the short-term mortality in a population-based cohort of elderly people in British Columbia who were prescribed conventional and atypical antipsychotic medications...
  43. ncbi request reprint Restrictions on antidepressant medications for children: a review of Medicaid policy
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA
    Psychiatr Serv 58:135-8. 2007
    ..This study evaluated Medicaid's prior-authorization policies restricting the prescribing of antidepressant medications for children...
  44. ncbi request reprint Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Occup Environ Med 45:1303-11. 2003
    ..Disease management programs for these conditions might have a positive return on investment (ROI). Health and productivity tracking surveys are needed to evaluate ROI and provide quality assurance...
  45. ncbi request reprint Lipid levels and bone mineral density
    Daniel H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02120, USA
    Am J Med 118:1414. 2005
    ..The aim of this study was to examine the relationship between lipid levels and bone mineral density...
  46. ncbi request reprint The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    JAMA 289:3095-105. 2003
    ..Uncertainties exist about prevalence and correlates of major depressive disorder (MDD)...
  47. pmc Patterns and correlates of contacting clergy for mental disorders in the United States
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Health Serv Res 38:647-73. 2003
    ..To present nationally representative data on the part played by clergy in providing treatment to people with mental disorders in the United States...
  48. ncbi request reprint Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial
    Jerry Avorn
    Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Control Clin Trials 23:757-73. 2002
    ....
  49. pmc Mental health service use among hurricane Katrina survivors in the eight months after the disaster
    Philip S Wang
    Interventional Research, National Institute of Mental Health, Bethesda, MD, USA
    Psychiatr Serv 58:1403-11. 2007
    ..This study examined use of mental health services among adult survivors of Hurricane Katrina in order to improve understanding of the impact of disasters on persons with mental disorders...
  50. ncbi request reprint Selective prescribing led to overestimation of the benefits of lipid-lowering drugs
    Robert J Glynn
    Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Clin Epidemiol 59:819-28. 2006
    ..Selective use of these drugs in frail people may confound these relationships...
  51. ncbi request reprint Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, Mass 02115, USA
    JAMA 293:2487-95. 2005
    ..Little is known about trends in suicidal ideation, plans, gestures, or attempts or about their treatment. Such data are needed to guide and evaluate policies to reduce suicide-related behaviors...
  52. ncbi request reprint Dopamine antagonists and the development of breast cancer
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 221 Longwood Ave, Boston, MA 02115, USA
    Arch Gen Psychiatry 59:1147-54. 2002
    ..Although animal studies have raised the possibility that prolactin-elevating dopamine antagonists used to treat psychotic disorders may initiate and promote breast cancers, epidemiologic studies in humans have been limited and inconsistent...
  53. pmc Health advisories and patterns of patient monitoring among new users of antidepressant medications
    Joshua J Gagne
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Suite 3030, 1620 Tremont St, Boston, MA 02120, USA
    J Clin Psychopharmacol 29:590-4. 2009
    ..We sought to identify patterns of patient monitoring after antidepressant initiation in British Columbia before and after issuance of health advisories...
  54. pmc Identification of hospitalizations for intentional self-harm when E-codes are incompletely recorded
    Amanda R Patrick
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Pharmacoepidemiol Drug Saf 19:1263-75. 2010
    ..However, rates of E-code completeness in US government and commercial claims databases are low due to issues with hospital billing software...
  55. pmc Delays in initial treatment contact after first onset of a mental disorder
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Health Serv Res 39:393-415. 2004
    ..To examine nationally representative patterns and predictors of delays in contacting a professional after first onset of a mental disorder...
  56. pmc Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable
    M Alan Brookhart
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital Harvard Medical School, Boston, MA 02120, USA
    Epidemiology 17:268-75. 2006
    ..Instrumental variable methods have been proposed as a potential approach to control confounding by indication in nonexperimental studies of treatment effects; however, good instruments are hard to find...
  57. ncbi request reprint Medicaid's prior authorization program and access to atypical antipsychotic medications
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Health Aff (Millwood) 26:750-60. 2007
    ..More than a year later, no state had changed its PA policy in response. We discuss the roles of Medicaid and other insurers in responding to emerging drug safety issues and their challenges in weighing drug risks and benefits...
  58. ncbi request reprint Claims data studies of sedative-hypnotics and hip fractures in older people: exploring residual confounding using survey information
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Geriatr Soc 53:948-54. 2005
    ..To identify the magnitude of confounding bias caused by factors not measured in claims data studies of sedative-hypnotic use and fractures...
  59. ncbi request reprint Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
    Ann H Partridge
    Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney Street, D1210, Boston, MA 02215, USA
    J Clin Oncol 21:602-6. 2003
    ..We sought to estimate adherence and predictors of nonadherence in women starting tamoxifen as adjuvant breast cancer therapy...
  60. ncbi request reprint Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    J Clin Psychopharmacol 24:632-8. 2004
    ..Using survey data, we determined the magnitude of such bias and corrected the association between SSRI use and hip fractures accordingly...
  61. ncbi request reprint Effects of efforts to increase response rates on a workplace chronic condition screening survey
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Med Care 40:752-60. 2002
    ..We evaluated these concerns by examining the prevalences and work impairments associated with chronic conditions across four HRA subsamples that differed in intensity of recruitment effort...
  62. doi request reprint Low socioeconomic status and mental health care use among respondents with anxiety and depression in the NCS-R
    Peter P Roy-Byrne
    Department of Psychiatry, Harborview Medical Center, University of Washington School of Medicine, 325 9th Ave, Box 359911, Seattle, WA 98104 2499, USA
    Psychiatr Serv 60:1190-7. 2009
    ....
  63. doi request reprint The STAR*D trial: revealing the need for better treatments
    Thomas R Insel
    National Institute of Mental Health, Bethesda, MD 20892 9669, USA
    Psychiatr Serv 60:1466-7. 2009
    ..However, initial and one-year remission rates (28% and 70%, respectively) suggest that important goals for treatment of this disabling disease remain out of reach and that the bar for antidepressants has been set far too low...
  64. pmc Adequacy of treatment for serious mental illness in the United States
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Public Health 92:92-8. 2002
    ..The purpose of this study was to assess the prevalence and correlates of treatment for serious mental illness...
  65. ncbi request reprint Clozapine use and risk of diabetes mellitus
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Clin Psychopharmacol 22:236-43. 2002
    ..Additional data from pharmacoepidemiologic studies and randomized controlled trials are needed to exclude the possibility of residual confounding and ensure the appropriate use of this agent...
  66. ncbi request reprint The economic burden of depression and the cost-effectiveness of treatment
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Int J Methods Psychiatr Res 12:22-33. 2003
    ..Further research is needed to overcome these barriers to providing high-quality care for depression and to ultimately reduce the enormous adverse economic impact of depression disorders...
  67. ncbi request reprint How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 13:11-9. 2004
    ..Although self-reports are often the only means available in routine practice, their accuracy and agreement with other data sources remain questionable...
  68. ncbi request reprint Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Geriatr Soc 50:117-24. 2002
    ..We sought to determine whether the use of urinary antispasmodics increases the risk of ventricular arrhythmias or sudden death...
  69. ncbi request reprint Psychotropic medication use for behavioral symptoms of dementia
    Philip S Wang
    Department of Psychiatry, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Curr Neurol Neurosci Rep 6:490-5. 2006
    ..Also, although various psychotropic medications used for behavioral disturbances in dementia patients may be somewhat effective, they have been increasingly associated with important safety risks...
  70. ncbi request reprint Parental anxiety associated with referral of a child to a pediatric cardiologist for evaluation of a Still's murmur
    Robert L Geggel
    Department of Cardiology, Children s Hospital, Boston, Massachusetts 02115, USA
    J Pediatr 140:747-52. 2002
    ..We assessed factors contributing to parental anxiety when children are referred to a cardiology clinic for evaluation of a Still's murmur...
  71. pmc Clinical differences among patients treated for mental health problems in general medical and specialty mental health settings in the National Comorbidity Survey Replication
    Lisa A Uebelacker
    Department of Psychiatry and Human Behavior, Brown University and Butler Hospital, Providence, RI 02906, USA
    Gen Hosp Psychiatry 28:387-95. 2006
    ..We explored whether differences in the clinical characteristics of patients treated in each sector (GM-only or SMH-only) or in both sectors (GM+SMH) may help to explain this finding...
  72. ncbi request reprint Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys
    Koen Demyttenaere
    JAMA 291:2581-90. 2004
    ..Little is known about the extent or severity of untreated mental disorders, especially in less-developed countries...
  73. ncbi request reprint Treatment and adequacy of treatment of mental disorders among respondents to the Mexico National Comorbidity Survey
    Guilherme Borges
    Instituto Nacional de Psiquiatria and Universidad Autonoma Metropolitana Xochimilco, Calzada Mexico Xochimilco No 101, Col San Lorenzo Huipulco, Mexico D F C P 14370, Mexico
    Am J Psychiatry 163:1371-8. 2006
    ..This study described the rate and adequacy of mental health service use among participants in the Mexico National Comorbidity Survey and the correlates of any 12-month treatment and of adequate treatment...
  74. ncbi request reprint Unmet need for services and interventions among adolescents with mental disorders
    Philip S Wang
    Am J Psychiatry 164:1-3. 2007
  75. pmc Delay of first treatment of mental and substance use disorders in Mexico
    Guilherme Borges
    National Institute of Psychiatry and the Metropolitan Autonomous University, Mexico City, Mexico
    Am J Public Health 97:1638-43. 2007
    ..We studied failure and delay in making initial treatment contact after the first onset of a mental or substance use disorder in Mexico as a first step to understanding barriers to providing effective treatment in Mexico...
  76. pmc Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication
    Benjamin G Druss
    Department of Health Policy and Management, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, USA
    Arch Gen Psychiatry 64:1196-203. 2007
    ..Concerns have been raised that this pattern might represent evidence of misallocation of treatment resources...
  77. ncbi request reprint Dropping out of mental health treatment: patterns and predictors among epidemiological survey respondents in the United States and Ontario
    Mark J Edlund
    UCLA Neuropsychiatric Institute, Los Angeles, CA, USA
    Am J Psychiatry 159:845-51. 2002
    ..The authors interviewed individuals treated for self-described mental health problems in the preceding year to examine patterns and predictors associated with dropping out of treatment...
  78. pmc Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School Boston, Mass 02115, USA
    J Gen Intern Med 17:504-11. 2002
    ..Addressing the epidemic of poor compliance with antihypertensive medications will require identifying factors associated with poor adherence, including modifiable psychosocial and behavioral characteristics of patients...
  79. ncbi request reprint Suicide risk during antidepressant treatment
    Gregory E Simon
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Am J Psychiatry 163:41-7. 2006
    ..The authors used population-based data to evaluate the risk of suicide death and serious suicide attempt in relation to initiation of antidepressant treatment...
  80. ncbi request reprint Do Canada and the United States differ in prevalence of depression and utilization of services?
    Helen Maria Vasiliadis
    Department of Psychiatry, Universite de Montreal, Montreal, Quebec, Canada
    Psychiatr Serv 58:63-71. 2007
    ..This study compared the prevalence of depression and the determinants of mental health service use in Canada and the United States...
  81. ncbi request reprint Distinguishing generalized anxiety disorder from major depression: prevalence and impairment from current pure and comorbid disorders in the US and Ontario
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston MA 02115, USA
    Int J Methods Psychiatr Res 11:99-111. 2002
    ..The paper closes with a discussion of the methodological complexities associated with generalizing to comorbidities that involve rare conditions or more than two disorders...